Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

Deal Watch October 2016

Deal Watch October 2016 330. Ocular Therapeutics (US). Regeneron (US). Licence collaboration. Hydrogel sustained release aflibercept (Eylea) for wet macular degeneration.

Lucentis claims speedy FDA review for myopia complication

Lucentis claims speedy FDA review for myopia complication Approval in a sizeable new patient population would help Roche recapture ground lost to Bayer and Regeneron's rival VEGF inhibitor Eylea (aflibercept), which has been growing at a phenomenal pace ... Eylea is not yet approved for mCNV in the US, although

NICE backs Bayer’s Eylea as first-line BRVO treatment

NICE backs Bayer’s Eylea as first-line BRVO treatment Recommends visual impairment therapy over current laser treatment. Bayer's Eylea (aflibercept) has been recommended for use on the NHS in England and Wales as a first-line treatment for adults ... Clinical data showed Eylea to achieve superior

Xarelto leads the charge at Bayer

Xarelto leads the charge at Bayer There were also gains for Eylea (aflibercept) for age-related macular degeneration (AMD) as well as prostate cancer drug Xofigo (radium Ra 223 dichloride) and Adempas (riociguat) for pulmonary artery hypertension. ... The company said these drugs are

NICE gives Bayer's Elyea a provisional 'no' for first-line use

NICE gives Bayer's Elyea a provisional 'no' for first-line use suitable. Bayer would also have to provide Eylea at the discount it agreed with the Department of Health under its patient access scheme. ... NICE has previously recommended Eylea to treatment wet age-related macular degeneration  and  diabetic macular

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics